An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
Min Shen,1,* Faming Gong,3,* Pengfei Pang,1,* Kangshun Zhu,1 Xiaochun Meng,1 Chun Wu,1 Jin Wang,1 Hong Shan,1,2 Xintao Shuai3,41Molecular Imaging Lab, Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; 2Institute of Intervention Radiology, Sun Yat-sen...
Guardado en:
Autores principales: | Shen M, Gong FM, Pang PF, Zhu KS, Meng XC, Wu C, Wang J, Shan H, Shuai XT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ae8245afe22402cb09490268e187559 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer
por: Chen Y, et al.
Publicado: (2012) -
Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
por: Zhang J, et al.
Publicado: (2017) -
Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy
por: Duan X, et al.
Publicado: (2018) -
Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1
por: Zhou P, et al.
Publicado: (2018) -
PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer
por: Chitra Risnayanti, et al.
Publicado: (2018)